FDA to Add Warning of Rare Nerve Condition to J&J Vaccine
July 12, 2021 | District of Columbia
The Food and Drug Administration will attach a label to the Johnson & Johnson coronavirus vaccine warning of a slightly increased risk of a rare nerve disorder known as Guillain-Barre syndrome.
Just 100 out of about 12,800,000 Americans who received the Johnson & Johnson vaccine developed the neurological condition. However, the FDA chose to add a warning label because the risk of developing Guillain-Barre syndrome is believed to be roughly three to five times higher in those who have taken the Johnson & Johnson vaccine.
